Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


With Sun Setting On Trump Admin, HHS Finalizes Regulatory Review Rule

Executive Summary

In a change from the draft, the final rule exempts device-specific regulations from scheduled review.

You may also be interested in...

Medicare Agency Further Delays SUNSET

The regulation-review policy has been mired in court cases and administrative red tape since it was proposed in 2020. A new Federal Register notice pushes back implementation to 22 September at the earliest.

Curtains For SUNSET: HHS Proposes Withdrawing Controversial Regulatory Review Rule

US HHS says rule, which would require reviews of most regulations every 10 years, would gobble up departmental resources and hurt public health.

SUNSET Goes Dark: HHS Withdraws Controversial Regulatory Review Rule

The US Department of Health and Human Services said the rule, which would require most regulations be reviewed every 10 years, would gobble departmental resources and could hurt the public health.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts